These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21170490)

  • 21. Neutrophil C5a receptor and the outcome in a rat model of sepsis.
    Guo RF; Riedemann NC; Bernacki KD; Sarma VJ; Laudes IJ; Reuben JS; Younkin EM; Neff TA; Paulauskis JD; Zetoune FS; Ward PA
    FASEB J; 2003 Oct; 17(13):1889-91. PubMed ID: 12897064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.
    Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA
    J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement-induced impairment of innate immunity during sepsis.
    Huber-Lang MS; Younkin EM; Sarma JV; McGuire SR; Lu KT; Guo RF; Padgaonkar VA; Curnutte JT; Erickson R; Ward PA
    J Immunol; 2002 Sep; 169(6):3223-31. PubMed ID: 12218141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functions of C5a receptors.
    Ward PA
    J Mol Med (Berl); 2009 Apr; 87(4):375-8. PubMed ID: 19189071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
    Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
    J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of C5a in inflammatory responses.
    Guo RF; Ward PA
    Annu Rev Immunol; 2005; 23():821-52. PubMed ID: 15771587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C5a, a therapeutic target in sepsis.
    Guo RF; Ward PA
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):57-65. PubMed ID: 18221134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-complement strategies in experimental sepsis.
    Ward PA; Riedemann NC; Guo RF; Huber-Lang M; Sarma JV; Zetoune FS
    Scand J Infect Dis; 2003; 35(9):601-3. PubMed ID: 14620141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
    Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
    J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.
    Lee H; Whitfeld PL; Mackay CR
    Immunol Cell Biol; 2008 Feb; 86(2):153-60. PubMed ID: 18227853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complement anaphylatoxin C5a induces apoptosis in adrenomedullary cells during experimental sepsis.
    Flierl MA; Rittirsch D; Chen AJ; Nadeau BA; Day DE; Sarma JV; Huber-Lang MS; Ward PA
    PLoS One; 2008 Jul; 3(7):e2560. PubMed ID: 18648551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical role of C5a in sickle cell disease.
    Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
    Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
    Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
    Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sepsis, complement and the dysregulated inflammatory response.
    Ward PA; Gao H
    J Cell Mol Med; 2009 Oct; 13(10):4154-60. PubMed ID: 19725914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.
    Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA
    FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement 5a receptor-mediated neutrophil dysfunction is associated with a poor outcome in sepsis.
    Xu R; Lin F; Bao C; Huang H; Ji C; Wang S; Jin L; Sun L; Li K; Zhang Z; Wang FS
    Cell Mol Immunol; 2016 Jan; 13(1):103-9. PubMed ID: 25726869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C5a receptor and thymocyte apoptosis in sepsis.
    Riedemann NC; Guo RF; Laudes IJ; Keller K; Sarma VJ; Padgaonkar V; Zetoune FS; Ward PA
    FASEB J; 2002 Jun; 16(8):887-8. PubMed ID: 12039868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of complement C5a and histones in septic cardiomyopathy.
    Fattahi F; Frydrych LM; Bian G; Kalbitz M; Herron TJ; Malan EA; Delano MJ; Ward PA
    Mol Immunol; 2018 Oct; 102():32-41. PubMed ID: 29914696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dark side of C5a in sepsis.
    Ward PA
    Nat Rev Immunol; 2004 Feb; 4(2):133-42. PubMed ID: 15040586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of C5a-induced immunologic derangement in sepsis.
    Xu R; Lin F; Bao C; Wang FS
    Cell Mol Immunol; 2017 Sep; 14(9):792-793. PubMed ID: 28782758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.